Otago to evaluate new Anti Ageing range of products for UK, Middle East and India

Otago Healthcare has signed an agreement with Access Healthcare FZ LLC based out of Switzerland to evaluate the market for a new novel range of anti-ageing products called Botarin. In this agreement, Otago will evaluate the market for an initial 6 months period exclusively before commercialisation into the retail sector.